The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Long-Term Mortality in Nonalcoholic Fatty Liver Disease: Is Liver Histology of Any Prognostic Significance?
Open accessAbstract
Over the last decade, a wealth of data has emerged illustrating both the rather benign clinical course of nonalcoholic fatty liver disease (NAFLD) in many individuals, and the unfavorable prognosis of this condition in others. Several studies on long-term mortality of patients suffering from NAFLD confirmed by imaging and/or liver biopsy have been reported. Studies with an average follow-up of at least 5 years are summarized in Table 1.1-10 Compared to the general population of same age and gender, NAFLD is associated with a significantly higher overall mortality1, 2, 4 and liver-related mortality.1, 2 The long-term prognosis of patients with NAFLD, however, varies across the disease stage. Although the terms simple steatosis and nonalcoholic steatohepatitis (NASH) are often used in studies on long-term prognosis to classify patient risk, differing definitions have been used across the studies. Despite that, however, some conclusions can be derived from pooling data from these studies together (Table 1). Within the first 15 years of follow-up, the prevalence of cirrhosis development is significantly higher in patients with NASH as compared to patients with simple steatosis (10.8% versus 0.7%, respectively, x2 = 23.3, P < 0.001). Consequently, the liver-related mortality is also significantly higher in patients with NASH as compared to simple steatosis (7.3% versus 0.9%, respectively, x2 = 16.7, P < 0.001). The overall mortality between these two groups, however, is not significantly different, although there is a trend toward a higher overall mortality in the NASH group (40.5% versus 32.5%, respectively, x2= 3.61, P < 0.1). NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis. None of the studies reported to date comparing overall and liver-related mortality of individuals with biopsy confirmed simple steatosis (as defined by steatosis alone or steatosis with mild inflammation/cellular injury) and the general population of same age and gender has found an increased mortality risk in those with simple steatosis. Thus, when we have to counsel patients with simple steatosis, it is safe to state that simple steatosis is not associated with a prognosis worse than expected in individuals of the same age and gender. On the contrary, the overall and liver-related mortality in patients with NASH is higher than expected in individuals of the same age and gender, but this observation comes from a single study that included only 71 patients with NASH.2 Unfortunately, because there is no consensus on what is the best definition of NASH, different histological criteria have been used in the various studies for defining NASH.2-4, 7 Most recently, the Pathology Subcommittee of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-sponsored NASH-clinical research network (CRN) has proposed a semiquantitative scoring system to grade and stage the several histological features of NAFLD.11 That scoring system is intended to be used in the design of clinical trials, not to replace the pathologist's judgment on the diagnosis of NASH, and it remains uncertain whether the use of this scoring system for NASH classification provides any prognostic information. In this issue of HEPATOLOGY, Soderberg et al.4 report an 80% (standardized mortality ratio 1.8, 95% CI 1.48-2.16) increased mortality in 256 patients with elevated liver enzymes who underwent liver biopsy and had a mean follow-up of 21 years. One-hundred and eighteen (46%) patients suffered from NAFLD, and the remaining had liver disease not related to NAFLD. Although the number of patients is too small to derive substantial conclusions, particularly for those with liver disease other than NAFLD, the study provides some interesting observations in the group of patients with NAFLD. First, the NAFLD group had a 70% (standardized mortality ratio 1.7; 95% CI 1.24-2.25) higher risk of dying as compared to a population of similar age and sex, and this increased risk is almost identical to that reported in two large prior studies.1, 2 Second, using the NASH-CRN histology scoring system,11 patients were divided into those with definitive NASH (n = 51) and with no definitive NASH (or non NASH, n = 67); the overall mortality in the group with definitive NASH (but not in the non NASH group) was significantly higher as compared to the general population of the same age and gender, similar to what was reported in a prior study.2 Third, as illustrated in Fig. 2A in the paper, overall mortality was almost identical between the definitive NASH and non NASH groups which also had been reported in another recent long-term follow-up study.3 The study by Soderberg at al.4 essentially reproduces several observations from prior long-term follow-up studies,1-3 but most intriguing is the reported similar overall-related and liver-related mortality between the groups with and without definitive NASH. There are two most likely explanations for the lack of di
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Self-citation
Cited by
Nonalcoholic Fatty Liver Disease: A Systematic Review
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,267
Nonalcoholic Steatohepatitis: A Review
Sheka, A. C., Adeyi, O., Thompson, J., Hameed, B., Crawford, P. A., & Ikramuddin, S. (2020) · JAMA · doi:10.1001/jama.2020.2298 · Cited by 1,379
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Extrahepatic complications of nonalcoholic fatty liver disease
Armstrong, M. J., Adams, L. A., Canbay, A., & Syn, W.-K. (2014) · Hepatology · doi:10.1002/hep.26717 · Cited by 600
Angulo, P., Bugianesi, E., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Barrera, F., Haflidadottir, S., Day, C. P., & George, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.057 · Cited by 502
Metadata
- Authors
- Angulo, P.
- Venue
- Hepatology
- Published
- 2010-02
- Volume
- 51
- Issue
- 2
- Pages
- 373-375
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1985958297
- Cited by
- 232
- References
- 2
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-Term Mortality in Nonalcoholic Fatty Liver Disease: Is Liver Histology of Any Prognostic Significance? https://app.cochat.ai/papers/10.1002/hep.23521
- The paper
- Angulo, P. (2010). Long-Term Mortality in Nonalcoholic Fatty Liver Disease: Is Liver Histology of Any Prognostic Significance? Hepatology. https://doi.org/10.1002/hep.23521
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.